Targeting cancer stemness: A new approach to target tumour metastasis in colorectal cancer

At COARE Holdings in the US, Dr Courtney W Houchen and Edwin Bannerman-Menson examine innovative ways to target and treat metastatic colorectal cancer (mCRC). Their research focuses on the ‘stemness’ […]

Read More…

Improving the effectiveness of an anticancer fluoropyrimidine by molecular hybridisation

Capecitabine (Cape) – a fluoropyrimidine used primarily in the treatment of breast and colorectal cancer – disrupts the synthesis of DNA in cancer cells following its conversion to 5-fluorouracil (FU). […]

Read More…

Probing Cancer: Immunotherapy and Molecular Imaging

The Singapore-based Cancer ImmunoTherapy Imaging (CITI) programme is a Singapore-wide collaborative research group, comprising 12 research institutes. CITI’s efforts are focused on the discovery and application of peptide-based imaging probes, […]

Read More…

A new weapon to boost cancer immunotherapy

In recent years, immunooncology has paved new avenues for effective treatment across cancer types. In addition to cytotoxic chemotherapy, we can now harness the power of the human immune response […]

Read More…

The genomics of cancer

Many cancers are associated with changes to our genetic material, DNA. These may be small, single unit substitutions, large rearrangements such as deletions or duplications of a part of the […]

Read More…

Spiking of urinary biomarker with exercise: A marker of muscle inflammation?

Seeking a sensitive biomarker of inflammation, Emeritus Professor Isao Okayasu of Kiryu University and Kitasato University, Japan and his colleagues have spent over two decades investigating chronic organ inflammation and […]

Read More…

One cell’s death is a microbe’s DINNR: How intestinal bacteria use our dying cells as fuel

Until now, a great deal has remained unknown about the relationship between programmed cell death and bacterial infections. However, recent work by Dr CJ Anderson and Professor Kodi Ravichandran from […]

Read More…